Celldex Therapeutics
CLDX
#4576
Rank
S$2.34 B
Marketcap
$35.28
Share price
-0.68%
Change (1 day)
-5.85%
Change (1 year)

Celldex Therapeutics (CLDX) - Cash on Hand

Cash on Hand as of September 2024 : S$1.01 Billion

According to Celldex Therapeutics's latest financial reports the company has S$1.01 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Celldex Therapeutics - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.55 B36.84%
2022-12-31S$0.40 B-25.93%
2021-12-31S$0.55 B114.58%
2020-12-31S$0.25 B196.32%
2019-12-31S$86.79 M-32.42%
2018-12-31S$0.12 B-31.12%
2017-12-31S$0.18 B-32.1%
2016-12-31S$0.27 B-33.02%
2015-12-31S$0.41 B54.36%
2014-12-31S$0.26 B-30.8%
2013-12-31S$0.38 B273.86%
2012-12-31S$0.10 B48.72%
2011-12-31S$69.04 M-12.27%
2010-12-31S$78.7 M-32.01%
2009-12-31S$0.11 B82.89%
2008-12-31S$63.29 M795.88%
2007-12-31S$7.06 M-88.74%
2006-12-31S$62.73 M60.88%
2005-12-31S$38.99 M-24.7%
2004-12-31S$51.78 M50.5%
2003-12-31S$34.4 M-20.91%
2002-12-31S$43.5 M-44.92%
2001-12-31S$78.98 M-9.18%
2000-12-31S$86.96 M283.51%
1999-12-31S$22.67 M54.32%
1998-12-31S$14.69 M36.18%
1997-12-31S$10.79 M-38.81%
1996-12-31S$17.63 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$1.66 B 63.62%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.12 B-87.60%๐Ÿ‡บ๐Ÿ‡ธ USA
S$93.78 M-90.78%๐Ÿ‡บ๐Ÿ‡ธ USA
S$12.12 B 1,091.93%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.39 B 1,216.40%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.78 B 468.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$5.5 M-99.46%๐Ÿ‡บ๐Ÿ‡ธ USA